MARCI STORY: Open Payments
NPI 1619913019 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 19 payments from 9 companies in 2025. Trend: 2023 $1,425 · 2024 $1,106 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $202 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Lundbeck LLC | 2 | $48 |
| Alkermes, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, HETLIOZ, TRINTELLIX, REXULTI, ARISTADA, AUSTEDO XR, CAPLYTA, Jornay PM.
Industry payments across FL — which companies pay providers there.
